| Dr Patty Peng-jung Chi, MD | |
|
701 E El Camino Real, Mountain View, CA 94040-2833 | |
| (650) 934-7888 | |
| Not Available |
| Full Name | Dr Patty Peng-jung Chi |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 701 E El Camino Real, Mountain View, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407898323 | NPI | - | NPPES |
| 00A822420 | Medicaid | CA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | University Healthcare Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760531198 PECOS PAC ID: 6305748799 Enrollment ID: O20040126000292 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Entity Name | Columbia Asthma & Allergy Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962687566 PECOS PAC ID: 4688606536 Enrollment ID: O20090904000403 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patty Peng-jung Chi, MD 325 Distel Cir, Los Altos, CA 94022-1408 Ph: () - | Dr Patty Peng-jung Chi, MD 701 E El Camino Real, Mountain View, CA 94040-2833 Ph: (650) 934-7888 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Vermont's aggressive health care reform initiatives can serve as a roadmap for other states, according to a Master of Public Health candidate at The University of Texas Health Science Center at Houston (UTHealth).
A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve.
The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
› Verified 7 days ago
Julia A Cronin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 Fax: 650-934-7895 | |
Dr. Steven Rubinstein, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 701 E El Camino Real, Medical Staff Office, Mountain View, CA 94040 Phone: 650-934-7888 | |
Michael Joseph Mulligan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 | |
Jamila C. Martin, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 | |
Dr. Philippe Begin, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2500 Grant Rd, Safar, Packard At El Camino Hospital, Mountain View, CA 94040 Phone: 650-561-2876 | |
Meng Chen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2500 Grant Rd Fl 4, Mountain View, CA 94040 Phone: 650-521-7237 |